This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific
Here's Why Momentum Investors Will Love Cintas (CTAS)
by Zacks Equity Research
Does Cintas (CTAS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Cintas (CTAS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Cintas (CTAS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cintas (CTAS) Looks Good: Stock Adds 8.7% in Session
by Zacks Equity Research
Cintas (CTAS) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Top Stock Reports for Johnson & Johnson, NextEra & Deere
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), NextEra (NEE) and Deere (DE).
Cintas (CTAS) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) fourth-quarter fiscal 2019 revenues increase year over year on the back of solid organic revenue growth in both its segments.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
Cintas (CTAS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 6.70% and 0.66%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks with Spectacular Earnings Charts
by Tracey Ryniec
These companies aren't just beating on earnings, their stocks are also on fire, hitting new 5-year highs.
Top Research Reports for Berkshire Hathaway, Pfizer & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Pfizer (PFE) and Danaher (DHR).
Cintas (CTAS) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in the Uniform Rental and Facility Services segment and a solid product portfolio are likely to drive Cintas' (CTAS) fiscal Q4 results. However, high cost of sales poses a concern.
Here's Why it is Worth Holding on to Cintas (CTAS) Stock Now
by Zacks Equity Research
Cintas (CTAS) is well placed to reap benefits of its enterprise resource planning system, buyouts and solid product portfolio. However, high integration costs and huge debts are concerning.
The Zacks Analyst Blog Highlights: Kimberly-Clark, McCormick, PepsiCo and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kimberly-Clark, McCormick, PepsiCo and Cintas
Trade War Escalates: Buy These 4 Dividend Aristocrats Now
by Tirthankar Chakraborty
Trump threatens to raise tariffs on $200 billion of Chinese goods and adds fuel to trade tensions. Thus, in order to safeguard your portfolio, investing in dividend aristocrats seems prudent.
Cintas (CTAS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Cintas (CTAS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Berry Global (BERY) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Berry Global's (BERY) second-quarter fiscal 2019 revenues decline year over year due to weaker operational performance in Health, Hygiene & Specialties, and Engineered Materials segments.
Macquarie's (MIC) Q1 Earnings Decline Y/Y, Revenues Rise
by Zacks Equity Research
Macquarie's (MIC) first-quarter 2019 revenues rise year over year owing to strong operational performance of its in IMTT and Atlantic Aviation segments.
Parker-Hannifin (PH) Q3 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Parker-Hannifin's (PH) third-quarter fiscal 2019 revenues fall year over year due to softness in North American segment.
Cimpress (CMPR) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cimpress (CMPR) reports disappointing third-quarter fiscal 2019 results, wherein both earnings and revenues miss estimates.
A. O. Smith (AOS) Q1 Earnings & Revenues Miss Estimates
by Zacks Equity Research
A. O. Smith's (AOS) first-quarter 2019 earnings and revenues decline year over year on account of weakness in China.
Ingersoll-Rand (IR) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Ingersoll-Rand (IR) reports impressive Q1 results backed by solid operational performance of its Climate segment.
IDEX (IEX) Q1 Earnings Top Estimates, Revenues Increase
by Zacks Equity Research
IDEX (IEX) posts impressive first-quarter results on the back of solid operational performance of its FMT segment.
Roper Technologies (ROP) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Impressive performance across the Application Software and Network Software & Systems segments drives Roper's (ROP) first-quarter 2019 results.
Fortune Brands (FBHS) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Impressive performance across Cabinets and Doors & Security segments drives Fortune Brands' (FBHS) first-quarter 2019 results.
Allegion (ALLE) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Allegion's (ALLE) Q1 earnings jump year over year on the back of solid performance across most of its segments.